Journal of Medicinal Chemistry
Volume 43, Issue 18 (September 7, 2000)
Copyright © 2000 American Chemical Society

Click [Full Article - PDF] to display or print the full article page image in PDF. Note: As of August 2000, Acrobat Reader 4.0 or later is recommended for PDFs.  

PERSPECTIVES

3351-3371

Caspases as Targets for Anti-Inflammatory and Anti-Apoptotic Drug Discovery Robert V. Talanian, Kenneth D. Brady, and Vincent L. Cryns [Full Article - PDF]

3372-3376

Discovery of (2S)-1-(4-Amino-2,3,5- trimethylphenoxy)-3-{4-[4-(4- fluorobenzyl)phenyl]-1-piperazinyl}-2- propanol Dimethanesulfonate (SUN N8075): A Dual Na+ and Ca2+ Channel Blocker with Antioxidant Activity Hirokazu Annoura, Kyoko Nakanishi, Tetsuya Toba, Naohiro Takemoto, Seiichi Imajo, Atsuko Miyajima, Yoshiko Tamura-Horikawa, and Shigeki Tamura [Full Article - PDF]

ARTICLES

3377-3385

Two Crystal Structures of Human Neutrophil Collagenase, One Complexed with a Primed- and the Other with an Unprimed-Side Inhibitor: Implications for Drug Design Enrico Gavuzzo, Giorgio Pochetti, Fernando Mazza, Carlo Gallina, Barbara Gorini, Silvana D'Alessio, Michael Pieper, Harald Tschesche, and Paul A. Tucker[Full Article - PDF]

3386-3399

Identification of MK-944a: A Second Clinical Candidate from the Hydroxylaminepentanamide Isostere Series of HIV Protease Inhibitors Bruce D. Dorsey, Colleen McDonough, Stacey L. McDaniel, Rhonda B. Levin, Christina L. Newton, Jacob M. Hoffman, Paul L. Darke, Joan A. Zugay-Murphy, Emilio A. Emini, William A. Schleif, David B. Olsen, Mark W. Stahlhut, Carrie A. Rutkowski, Lawrence C. Kuo, Jiunn H. Lin, I-W. Chen, Stuart R. Michelson, M. Katharine Holloway, Joel R. Huff, and Joseph P. Vacca[Full Article - PDF]

3400-3407

Synthesis and Biological Activity of a Novel 11a-Homo (Cyclohexyl) Prostaglandin Peter G. Klimko, Terry L. Davis, Brenda W. Griffin, and Najam A. Sharif[Full Article - PDF]

3408-3419

Subtype-Selective N-Methyl-D-Aspartate Receptor Antagonists: Synthesis and Biological Evaluation of 1-(Heteroarylalkynyl)-4-benzylpiperidines Jon L. Wright, Tracy F. Gregory, Suzanne R. Kesten, Peter A. Boxer, Kevin A. Serpa, Leonard T. Meltzer, and Lawrence D. Wise , Stephen A. Espitia, Christopher S. Konkoy, Edward R. Whittemore, and Richard M. Woodward[Full Article - PDF]

3420-3427

Structure-Activity Studies Including a (CH2-NH) Scan of Peptide YY (PYY) Active Site, PYY(22-36), for Interaction with Rat Intestinal PYY Receptors: Development of Analogues with Potent in Vivo Activity in the Intestine Ambikaipakan Balasubramaniam, Zhiyong Tao, Weixu Zhai, Meiczyslawa Stein, Sulaiman Sheriff, William T. Chance, Josef E. Fischer, Peter E. Eden, John E. Taylor, Carson D. Liu, David W. McFadden, Thierry Voisin, Claude Roze, and Marc Laburthe[Full Article - PDF]

3428-3433

A New Class of Potential Chloroquine-Resistance Reversal Agents for Plasmodia: Syntheses and Biological Evaluation of 1-(3'-Diethylaminopropyl)-3-(substituted phenylmethylene)pyrrolidines Sanjay Batra, Pratima Srivastava, Kamal Roy, V. C. Pandey, and A. P. Bhaduri[Full Article - PDF]

3434-3442

Difluoro Ketone Peptidomimetics Suggest a Large S1 Pocket for Alzheimer's -Secretase: Implications for Inhibitor Design Chad L. Moore, Dartha D. Leatherwood, Thekla S. Diehl, Dennis J. Selkoe, and Michael S. Wolfe[Full Article - PDF]

3443-3447

Privileged Molecules for Protein Binding Identified from NMR-Based Screening Philip J. Hajduk, Mark Bures, Jens Praestgaard, and Stephen W. Fesik[Full Article - PDF]

BRIEF ARTICLES

3448-3452

QSAR Based on Biological Microcalorimetry Maria Luiza C. Montanari, Anthony E. Beezer, Carlos A. Montanari, and Dorila Piló-Veloso[Full Article - PDF]